Results · Apr-Jun 2026 · filed 12 Aug 2026
GKB Ophthalmics Q1 FY27 results
Sales grew 2% to ₹33 crore from ₹32.3 crore in Apr-Jun 2025.
Operating profit grew 236% to ₹2.7 crore, an operating margin of 8.2% (up 5.7 points from a year ago).
Net profit turned positive: ₹1.8 crore against a loss of ₹0.64 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +11%, net profit +65%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 33.0 | 32.3 | +2% |
| Operating profit (EBITDA) | 2.7 | 0.8 | +236% |
| Operating margin | 8.2% | 2.5% | +5.7 pts |
| Net profit | 1.8 | -0.6 | turns positive |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 12 Aug 2026Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026.
- 12 Aug 2026Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Ltd., Held On August 12, 2026
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.